amgen - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,228 -0.12%

DJIA 49,519 -0.58%

Nasdaq 27,697 +0.62%

DAX 24,274 +1.63%

Gold $4,196 +0.16%

Oil $102.54 -2.40%

BTC $78,184 +2.22%

VIX 19.78 +2.33%

EUR/USD 1.1785 -0.02%

ETH $2,299 +1.60%

S&P 500 7,228 -0.12%

DJIA 49,519 -0.58%

Nasdaq 27,697 +0.62%

DAX 24,274 +1.63%

Gold $4,196 +0.16%

Oil $102.54 -2.40%

BTC $78,184 +2.22%

VIX 19.78 +2.33%

EUR/USD 1.1785 -0.02%

ETH $2,299 +1.60%

amgen

Amgen Earnings concept with premium biotech drug vials under dramatic lighting

Amgen Earnings -5.3% Plunge: Guidance Shock Despite Upgrade

By Maik Kemper • 2h ago

Amgen Earnings concept with premium biotech drug vials under dramatic lighting

Video

Amgen Earnings -5.3% Plunge: Guidance Shock Despite Upgrade

By Maik Kemper • 2h ago

Are the latest Amgen Earnings a buying opportunity after the stock’s sudden plunge, or a warning sign that growth is stalling? Maik Kemper Editor in…